Shenouda Maged 4
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
Shenouda Maged
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-11-05$2.20/sh+500,000$1,100,000→ 788,335 total
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Common Stock